Related Experiment Video
Updated: Mar 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Medication adherence to secondary prevention after ischemic cerebrovascular disease: a real-world outcomes analysis
Sabrina M Stollberg1, Andri Signorell1, Andreas R Luft2,3
1Department of Health Sciences, Helsana Group, Zurich, Switzerland.
Insights
Low adherence to secondary prevention for ischemic cerebrovascular disease (ICD) is common, increasing risks. Improving patient compliance with medications like lipid-lowering drugs is crucial for better outcomes and reduced mortality.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Ischemic cerebrovascular disease (ICD) represents a significant global health challenge.
- Non-adherence to secondary prevention strategies for ICD leads to recurrent events and increased disability.
- Real-world data on medication adherence for secondary prevention of ICD is limited.
Purpose of the Study:
- To assess adherence rates to secondary preventive medications in patients with ICD.
- To evaluate the impact of medication adherence on clinical outcomes in ICD patients.
Main Methods:
- Retrospective observational study using Swiss health insurance claims data (2017-2021).
- Included 9,911 patients aged 18+ hospitalized for ICD.
- Medication adherence measured by medication possession ratio (MPR ≥ 0.80 for high adherence).
- Outcomes included all-cause death, recurrent stroke, nursing home admission, and major adverse cardiovascular events.
Main Results:
- High adherence rates varied: lipid-lowering drugs (63.2%), antihypertensives (55.4%), antiplatelets (50.0%).
- Female patients showed significantly lower adherence to lipid-lowering drugs compared to men.
- High adherence to lipid-lowering drugs was associated with reduced all-cause death (HR 0.86).
- Direct oral anticoagulants and antihypertensives showed a trend towards a protective effect with high adherence.
Conclusions:
- A substantial number of patients exhibit low adherence or are non-users of essential secondary preventive medications for ICD.
- Insufficient secondary prevention is linked to increased mortality.
- Enhanced awareness and improved patient compliance are necessary to mitigate risks associated with ICD.
Introduction:
Ischemic cerebrovascular disease (ICD) poses a major global burden. Non-adherence to medical secondary prevention leads to recurrent events and disability. Real-world data on adherence to preventive medications is scarce. The objective here is to determine adherence to secondary prevention of ICD and its effect on clinical outcomes.
Methods:
This retrospective observational study was based on claims data from a large Swiss health insurance. We studied patients aged 18 years or older, who were hospitalized for ICD between 2017 and 2021. Patients' one-year medication adherence was determined by the medication possession ratio (MPR, high adherence defined as MRP ≥ 0.80). Outcome variables were all-cause death, recurrent stroke, admission to nursing home, and major adverse cardiovascular events.
Results:
A total of 9,911 patients with ischemic stroke or TIA were included in the analysis. Lipid-lowering drugs (LLD) had the largest proportion of high adherence users (63.2%), followed by antihypertensives (55.4%) and antiplatelets (50.0%). Female patients were 37% less likely to adhere to LLD therapy than men, highlighting a significant gender gap. Users with high adherence to LLD had a significantly reduced risk for all-cause death (HR 0.86, 95% CI 0.79, 0.94); Direct oral anticoagulants (HR 0.88, 95% CI 0.78, 1.00) and antihypertensives (HR 0.93, 95% CI 0.85, 1.01) showed a trend towards a protective effect.
Discussion:
A remarkable proportion of patients were non-users or had low adherence to medical secondary prevention. Since insufficient secondary prevention may lead to an increased all-cause death rate, efforts are needed to raise awareness among healthcare professionals and improve patient compliance.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis IV: Nursing Management